ClassID:

21432

A61K49/0047 - CPC Classification

Classification description:

Preparations for testing; Preparation for luminescence or biological staining; Luminescence; Fluorescence characterised by the fluorescent group the fluorescent agent being a peptide or protein used for imaging or diagnosis Green fluorescent protein [GFP]

Recent Application in this class:
#1
20250339706
2025-11-06

TREATMENT INTERVALS FOR USE OF COMPOSITIONS COMPRISING ENERGY ABSORBING MATERIALS FOR DERMATOLOGICAL APPLICATIONS

#2
20250313675
2025-10-09

Facile Assembly of Soft Nanoarchitectures and Co-Loading of Hydrophilic and Hydrophobic Molecules via Flash Nanoprecipitation

#3
20250011367
2025-01-09

CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF

#4
20240252689
2024-08-01

POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS

#5
20240247068
2024-07-25

NOVEL PROTEIN SPECIFICALLY BINDING TO CALRETICULIN AND HAVING HUMAN FIBRONECTIN DOMAIN III SCAFFOLD AND USE THEREOF

#6
20240122861
2024-04-18

ELECTRORESPONSIVE BIOPOLYMER CAPSULES FOR ELECTRICALLY MEDIATED DELIVERY OF ACTIVES

#7
20240082597
2024-03-14

TREATMENT INTERVALS FOR USE OF COMPOSITIONS COMPRISING ENERGY ABSORBING MATERIALS FOR DERMATOLOGICAL APPLICATIONS

#8
20220218847
2022-07-14

COMPOSITIONS AND METHODS CHARACTERIZING METASTASIS

#9
20220177523
2022-06-09

CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF

#10
20220002502
2022-01-06

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#11
20210244673
2021-08-12

Bubble manufacturing container

#12
20210077631
2021-03-18

COMPOSITIONS AND METHODS FOR MODIFYING THE SURFACE OF CELLS AND METHODS OF USE

#13
20210059578
2021-03-04

REAGENT COATED LENSES

#14
20200405885
2020-12-31

MAGNETIC RESONANCE IMAGING (MRI) CONTRAST AGENTS AND USE THEREOF

#15
20200385427
2020-12-10

Cell penetrating peptides and methods of making and using thereof

#16
20200338360
2020-10-29

Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications

#17
20200255603
2020-08-13

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#18
20200108158
2020-04-09

TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS

#19
20200061387
2020-02-27

OPTOGENETIC THERAPEUTIC AND METHOD OF TREATING RETINAL DEGENERATIVE AND NEURODEGENERATIVE DISEASES

#20
20190262476
2019-08-29

METHOD FOR MEASUREMENT AND CONTROL OF INTRACULAR VEGF CONCENTRATION

#21
20190231891
2019-08-01

Compositions and methods for modifying the surface of cells and methods of use

#22
20180291072
2018-10-11

Human-derived ferritin monomer fragment and fusion polypeptide using same

#23
20180195050
2018-07-12

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#24
20180116971
2018-05-03

Method for manufacturing bubbles and bubbles

#25
20180104146
2018-04-19

Bubble manufacturing container

#26
20180031583
2018-02-01

Phosphatidylethanolamine-specific probes

#27
20180022878
2018-01-25

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

#28
20170355730
2017-12-14

Cell penetrating peptides and methods of making and using thereof

#29
20170190743
2017-07-06

Cell penetrating peptides and methods of making and using thereof

#30
20170080109
2017-03-23

Host cells with artificial endosymbionts

#31
20170000894
2017-01-05

Compositions and methods for modifying the surface of cells and methods of use

#32
20160367600
2016-12-22

Administration of Intact Mammalian Cells to the Brain by the Intranasal Route

#33
20160282331
2016-09-29

Host cells with artificial endosymbionts

#34
20160250356
2016-09-01

Targeted contrast agents and methods for targeting contrast agents

#35
20160193132
2016-07-07

Light-absorbing compositions and methods of use

#36
20160151512
2016-06-02

Cell-penetrating peptide, conjugate comprising same and composition comprising same

#37
20150361145
2015-12-17

Fluorescent fusion protein

#38
20150258211
2015-09-17

Hydrogels for delivery of therapeutic polypeptides

#39
20150196639
2015-07-16

Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications

#40
20150175976
2015-06-25

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#41
20140004051
2014-01-02

Co-crystals and salts of contrast agents and imaging

#42
20130243689
2013-09-19

Multi-compartmental macrophage delivery

#43
20130142732
2013-06-06

RECOMBINANT FLUORESCENT NANOPARTICLES

#44
20130058871
2013-03-07

METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY

#45
20130017148
2013-01-17

SYSTEMS FOR PRODUCING MULTILAYERED PARTICLES, FIBERS AND SPRAYS AND METHODS FOR ADMINISTERING THE SAME

#46
20120322724
2012-12-20

Molecules for targeting compounds to various selected organs or tissues

#47
20120143024
2012-06-07

Recombinant bacteriophage for detection of nosocomial infection

#48
20110293527
2011-12-01

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#49
20110251471
2011-10-13

IMPLANTABLE POWER SOURCES AND SENSORS

#50
20110111480
2011-05-12

Telomelysin/GFP-expressing recombinant virus

#51
20110044981
2011-02-24

METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY FIBROTIC DISORDERS

#52
20110044907
2011-02-24

IN VIVO SCREENING ASSAYS

#53
20100329977
2010-12-30

METHOD FOR IMAGING TUMOR TISSUE

#54
20100272822
2010-10-28

NANOCELL DRUG DELIVERY SYSTEM

#55
20100272651
2010-10-28

METHOD FOR ASSESSING POTENTIAL FOR TUMOR DEVELOPMENT AND METASTASIS

#56
20100247433
2010-09-30

Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells

#57
20100203611
2010-08-12

Nuclear translocation peptide

#58
20100184948
2010-07-22

Molecules for targeting compounds to various selected organs or tissues

#59
20100146646
2010-06-10

METHOD OF MONITORING RETINOPATHY

#60
20100068148
2010-03-18

ENHANCED RESOLUTION OF TUMOR METASTASIS USING A SKIN FLAP MODEL

#61
20100008857
2010-01-14

Hexatriene-β-carbonyl compound

#62
20100004390
2010-01-07

BIODEGRADABLE METAL-CHELATING POLYMERS AND VACCINES

#63
20090297441
2009-12-03

Imaging Agents

#64
20090249500
2009-10-01

SYSTEM FOR MONITORING BACTERIAL TUMOR TREATMENT

#65
20090170960
2009-07-02

Peptide lipid-containing carrier and method for introducing compound into cells using same

#66
20090162425
2009-06-25

METHODS AND COMPOSITIONS FOR INHIBITING UNDESIRABLE CELLULAR PROLIFERATION BY TARGETED LIPOSOME DELIVERY OF ACTIVE AGENTS

#67
20090155287
2009-06-18

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#68
20090123382
2009-05-14

Light emitting microorganisms and cells for diagnosis and therapy of tumors

#69
20090117049
2009-05-07

Light emitting microorganisms and cells for diagnosis and therapy of tumors

#70
20090117048
2009-05-07

Light emitting microorganisms and cells for diagnosis and therapy of tumors

#71
20090117047
2009-05-07

Light emitting microorganisms and cells for diagnosis and therapy of tumors

#72
20090104123
2009-04-23

Targeted contrast agents and methods for targeting contrast agents

#73
20090098529
2009-04-16

Methods for attenuating virus strains for diagnostic and therapeutic uses

#74
20090053244
2009-02-26

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#75
20080319287
2008-12-25

Implantable power sources and sensors

#76
20080260725
2008-10-23

Tag and target delivery system

#77
20080260699
2008-10-23

Adminstration of intact mammalian cells to the brain by the intranasal route

#78
20080199529
2008-08-21

NANOPARTICLE DELIVERY VEHICLE

#79
20080187487
2008-08-07

METHODS FOR PRODUCING MULTILAYERED PARTICLES, FIBERS AND SPRAYS AND METHODS FOR ADMINISTERING THE SAME

#80
20080181849
2008-07-31

Methods, kits and compositions comprising crotamine

#81
20080109914
2008-05-08

DIFFERENTIAL LABELING OF CELLS

#82
20080095712
2008-04-24

Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in nematodes

#83
20080076792
2008-03-27

Heterobifunctional polymeric bioconjugates

#84
20080032283
2008-02-07

TELOMELYSIN/GFP-EXPRESSING RECOMBINANT VIRUS

#85
20070296099
2007-12-27

Systems for producing multilayered particles, fibers and sprays and methods for administering the same

#86
20070276208
2007-11-29

Process for identifying and treating specified cell types

#87
20070274923
2007-11-29

Non-invasive real-time in vivo bioluminescence imaging of local Ca2+ dynamics in living organisms

#88
20070098637
2007-05-03

Generation and use of vasculogenic tumors and products derived from same

#89
20070092449
2007-04-26

Methods for direct visualization of active synapses

#90
20070053845
2007-03-08

Nanocell drug delivery system

#91
20060173362
2006-08-03

Methods of medical imaging using quantum dots

#92
20060067890
2006-03-30

Telomelysin/GFP-expressing recombinant virus

#93
20050221270
2005-10-06

Process for identifying cancerous and/or metastatic cells of a living organism

#94
20050152838
2005-07-14

Method for detecting cancer cells and monitoring cancer therapy

#95
20050069491
2005-03-31

Vaccinia virus for diagnosis and therapy of tumors

#96
20050002865
2005-01-06

Diagnostic/therapeutic agents

#97
15294492
2020-03-03

Tools to detect, track and target cancer cells in vivo